Sign Up Today and Learn More About Trigemina Stock

Invest in or calculate the value of your shares in Trigemina or other pre-IPO companies through EquityZen's platform.

Get Started

Trigemina Stock

Trigemina develops non-opiate drug formulations and delivery systems for pain therapy.

About Trigemina Stock

Founded

2006

Headquarters

Moraga, CA, US

Total Funding

23.1M

Trigemina, Inc. develops non-opiate drug formulations and delivery systems for the pain therapy. The company’s products include TI-001, an intranasal oxytocin that targets chronic and sub-acute head pain; and TI-002, a non-opioid treatment that addresses a range of pain, including neuropathic pain throughout the body. Its drugs are delivered via the nasal-cerebral pathway. The company was founded in 2006 and is based in Mountain View, California.

Trigemina Management

Leadership team at Trigemina

Chief Medical Officer

Shashidhar Kori

Co-Founder

Martin Angst

Locked Features

Join now and verify your accreditation status to gain access to:

  • Trigemina current valuation
  • Trigemina stock price
  • Available deals in Trigemina and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Trigemina stock?

Accredited investors can buy pre-IPO stock in companies like Trigemina through EquityZen funds. These investments are made available by existing Trigemina shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Trigemina stock?

Shareholders can sell their Trigemina stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."